Caricamento...
Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade
The aim of this study was to evaluate the effect of zoledronic acid (ZA) on bone mineral density (BMD) in patients with prostate cancer receiving combined androgen blockade (CAB) as a first-line androgen deprivation therapy. Patients receiving CAB for prostate cancer without bone metastasis were can...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4197198/ https://ncbi.nlm.nih.gov/pubmed/25332886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-586 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|